Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?

Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study

(2010) Pawel Szulc et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Aging, exercise, and muscle protein metabolism

(2009) René Koopman et al.   JOURNAL OF APPLIED PHYSIOLOGY

Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat

(2008) Guido Lastra et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice

(2008) Melissa Braga et al.   APOPTOSIS

Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles

(2008) K. Swaminathan et al.   DIABETOLOGIA

The developmental origins of sarcopenia

(2008) A. A. Sayer et al.   Journal of Nutrition Health & Aging